ProQuest, part of Cambridge Information Group, US, has renewed its exclusive aggregation agreement with Elsevier to make medical journal, The Lancet, available to subscribers of ProQuest's popular health sciences databases. The journal is being made available in full-text.
In addition, the full text of two further essential journals - The Lancet Infectious Diseases and The Lancet Neurology - will also be aggregated only through ProQuest. A fourth key resource for medical practitioners, researchers and students, The Lancet Oncology, will be available to ProQuest users in full text as well.
The agreement is part of ProQuest's ongoing strategy to support its STM customers with highly respected and authoritative titles. The Lancet is known for its independent, authoritative voice in global medicine. Its publishing history includes reports on numerous medical breakthroughs since 1823, including shell shock therapy, penicillin, and birth defects to more recent medical advancements such as the description of a new variant of Creutzfeldt-Jakob disease and the identification of coronavirus as a possible cause of SARS.
New in 2009, researchers will have access to three more Lancet journals - The Lancet Infectious Diseases, The Lancet Neurology and The Lancet Oncology. These monthly journals contain review, opinion, original research and news covering international issues relevant to clinical infectious diseases specialists, neurologist, and clinical cancer specialists. The Lancet journals will be available to subscribers through ProQuest Medical Library, ProQuest Health and Medical Complete, ProQuest MEDLINE with Full Text, ProQuest Nursing & Allied Health Source, and ProQuest Pharma Collection.
The ProQuest Health Sciences portfolio has seen significant developments in 2008 and additional unique resources are planned for 2009.
